Advertisement

Topics

Pfizer to introduce Inflectra for injection in US

19:00 EDT 18 Oct 2016 | Pharmaceutical Technology

US-based pharmaceutical company Pfizer has announced plans to introduce Inflectra (infliximab-dyyb) for injection, a biosimilar of REMICADE (infliximab) in the US next month.

Original Article: Pfizer to introduce Inflectra for injection in US

NEXT ARTICLE

More From BioPortfolio on "Pfizer to introduce Inflectra for injection in US"

Quick Search
Advertisement
 

Relevant Topics

Pfizer
Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...